Literature DB >> 11081393

Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.

N Blot1, P Schneider, P Young, C Janvresse, D Dehesdin, P Tron, J P Vannier.   

Abstract

Herpes simplex virus (HSV) causes serious problems in immuno-compromised patients such as those receiving a bone marrow transplant (BMT) for a hematological malignancy. Resistance to acyclovir (ACV) is a growing major concern. Foscarnet is a non-thymidine kinase-dependent agent, but the emergence of ACV and foscarnet-resistant HSV requires a new therapeutic approach. We describe a girl treated with cidofovir for a life-threatening ACV-resistant HSV infection after an unrelated BMT for a relapse of an acute myeloblastic leukemia (AML).

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11081393     DOI： 10.1038/sj.bmt.1702591

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  10 in total

1.  Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.

Authors:  Masayuki Saijo; Tatsuo Suzutani; Shigeru Morikawa; Ichiro Kurane
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 2.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

4.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

5.  Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Authors:  C Danve-Szatanek; M Aymard; D Thouvenot; F Morfin; G Agius; I Bertin; S Billaudel; B Chanzy; M Coste-Burel; L Finkielsztejn; H Fleury; T Hadou; C Henquell; H Lafeuille; M E Lafon; A Le Faou; M C Legrand; L Maille; C Mengelle; P Morand; F Morinet; E Nicand; S Omar; B Picard; B Pozzetto; J Puel; D Raoult; C Scieux; M Segondy; J M Seigneurin; R Teyssou; C Zandotti
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.

Authors:  Adalbert Krawczyk; Michaela A E Arndt; Ludger Grosse-Hovest; Wilko Weichert; Bernd Giebel; Ulf Dittmer; Hartmut Hengel; Dirk Jäger; Karl E Schneweis; Anna M Eis-Hübinger; Michael Roggendorf; Jürgen Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

7.  Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo.

Authors:  Wei Wang; Cuijing Xu; Jianqiang Zhang; Jinpeng Wang; Rilei Yu; Dongping Wang; Ruijuan Yin; Wenmiao Li; Tao Jiang
Journal:  Br J Pharmacol       Date:  2020-01-23       Impact factor: 8.739

Review 8.  Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.

Authors:  Sabine Breuer; Margit Rauch; Susanne Matthes-Martin; Thomas Lion
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.476

Review 9.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

Review 10.  Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  Ren Lin; Qifa Liu
Journal:  J Hematol Oncol       Date:  2013-12-17       Impact factor: 17.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.